Background: Little is known about the long-term outcomes after drug-eluting stent (DES) implantation in saphenous vein graft (SVG) lesions. The first randomized trial comparing DES with bare metal stents (BMS) in SVGs reported higher mortality in the DES group at 32 months.
Results:
Mean age was 67 ± 9 years and all patients were men. The indications for angiography and stenting included acute coronary syndrome in 60%, and stable angina in 31%. The mean SVG age was 12 ± 6 years. The baseline characteristics of the patients in the 2 study groups were similar. Diabetes was present in 44%. The territory supplied by the target SVGs was the left anterior descending artery in 28%, the circumflex in 38%, and the right coronary artery in 34%. An embolic protection device was used in 54% of the lesions. Procedural success was achieved in 77 patients (96%). The long-term outcomes after stenting are shown in the Table. 
